Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2015 Jan 01;1012:e0146035. doi: 10.1371/journal.pone.0146035.
Show Gene links
Show Anatomy links
A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx.
Bahamonde MI
,
Serra SA
,
Drechsel O
,
Rahman R
,
Marcé-Grau A
,
Prieto M
,
Ossowski S
,
Macaya A
,
Fernández-Fernández JM
.
???displayArticle.abstract???
Mutations in the CACNA1A gene, encoding the pore-forming CaV2.1 (P/Q-type) channel α1A subunit, result in heterogeneous human neurological disorders, including familial and sporadic hemiplegic migraine along with episodic and progressive forms of ataxia. Hemiplegic Migraine (HM) mutations induce gain-of-channel function, mainly by shifting channel activation to lower voltages, whereas ataxia mutations mostly produce loss-of-channel function. However, some HM-linked gain-of-function mutations are also associated to congenital ataxia and/or cerebellar atrophy, including the deletion of a highly conserved phenylalanine located at the S6 pore region of α1A domain III (ΔF1502). Functional studies of ΔF1502 CaV2.1 channels, expressed in Xenopus oocytes, using the non-physiological Ba2+ as the charge carrier have only revealed discrete alterations in channel function of unclear pathophysiological relevance. Here, we report a second case of congenital ataxia linked to the ΔF1502 α1A mutation, detected by whole-exome sequencing, and analyze its functional consequences on CaV2.1 human channels heterologously expressed in mammalian tsA-201 HEK cells, using the physiological permeant ion Ca2+. ΔF1502 strongly decreases the voltage threshold for channel activation (by ~ 21 mV), allowing significantly higher Ca2+ current densities in a range of depolarized voltages with physiological relevance in neurons, even though maximal Ca2+ current density through ΔF1502 CaV2.1 channels is 60% lower than through wild-type channels. ΔF1502 accelerates activation kinetics and slows deactivation kinetics of CaV2.1 within a wide range of voltage depolarization. ΔF1502 also slowed CaV2.1 inactivation kinetic and shifted the inactivation curve to hyperpolarized potentials (by ~ 28 mV). ΔF1502 effects on CaV2.1 activation and deactivation properties seem to be of high physiological relevance. Thus, ΔF1502 strongly promotes Ca2+ influx in response to either single or trains of action potential-like waveforms of different durations. Our observations support a causative role of gain-of-function CaV2.1 mutations in congenital ataxia, a neurodevelopmental disorder at the severe-most end of CACNA1A-associated phenotypic spectrum.
???displayArticle.pubmedLink???
26716990
???displayArticle.pmcLink???PMC4696675 ???displayArticle.link???PLoS One
Fig 1. Brain MRI of the proband at the age of 14 months (A), 28 months (B), and 4 and a half years (C,D).After the initial normal findings (A), note the progressive cerebellar atrophy mainly involving the complete vermis (indicated by the arrows in B, C). The hemispheres, displaying prominence of the cerebellar folia, were eventually affected (D).
Fig 2. De novo heterozygous CACNA1A deletion in congenital ataxia with cerebellar atrophy.(A) Pedigree of the affected individual carrying the de novo heterozygous ΔF1502 mutation. White symbols denote healthy individuals and grey, congenital ataxia. (B) Electropherograms showing the deleted nucleotides (bracket) (NM_001127221.1-transcript variant 3:c.4503-4505delCTT) leading to a F1052 deletion (NP_001120693.1). Note the double wild-type (WT) and mutant (ΔF1502) sequence in the patient’s electropherogram (heterozygous mutation carrier).
Fig 3. Evolutionary conservation of the F1502 residue and predicted location at the channel pore.(A) Sequence alignment of individual S6 segments at domains I to IV (DI-DIV) of human CaV2.x channel α1 subunits (P/Q type CaV2.1; N-type CaV2.2; R-type CaV2.3), human CaV1.x (L-type) channel α1 subunits, and the bacterial sodium channel NaVAb (top); sequence alignment of S6-DIII of CaV2.1 channels from different species (as indicated). The three Phenylalanine’s group (in red) is conserved in the human CaV2.1 channel α1A subunit, where F1502 is located at the third position. This particular amino acid residue is only conserved in S6-DIII of CaV2 type channels. The phenylalanine’s group is totally conserved in S6-DIII of CaV2.1 channels from different species. The alignments were performed with T-Coffee (T-Coffee). (B,C,D) Location of the F1502 homologous methionine residue (M209), using the NaVAb structure as a model (PDB 4EKW). A methionine residue is also present at the F1502 position in L-type channels. The side view (B) show a red highlighted M209 residue in NaVAb, which lines the inner pore vestibule of the channel. A view from the cytoplasm looking up through the channel pore show the arrangement of M209 residue in the four NaVAb subunits (C), and a zoom of the pore region from the same view is shown in (D). Images were generated using UCSF Chimera package. Chimera is developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS P41-GM103311) [79].
Fig 4. ΔF1502 induces a gain-of-function in the heterologously expressed CaV2.1 channel by affecting its activation and deactivation properties.(A) Representative current traces elicited by 20 ms depolarizing pulses from -80 mV to the indicated voltages (inset), illustrating the difference in voltage-dependence and activation kinetics between wild-type (WT) (left) and ΔF1502 (right) CaV2.1 channels. Dotted lines indicate the zero current level. (B) Representative current traces showing distinct deactivation kinetics of WT (left) and ΔF1502 (right) CaV2.1 channels, obtained by hyperpolarizing the cells during 30 ms at the indicated voltages (inset) following a 20 ms depolarizing pulse to +20 mV (for WT channels) or -5 mV (for ΔF1502 channels). The zero current level is indicated by dotted lines. (C) Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 27) and ΔF1502 (filled circles, n = 19) CaV2.1 channels expressed in tsA-201 HEK cells. Red box indicates the voltage range at which peak Ca2+ current densities through ΔF1502 channels exceed those produced by WT channels. Average V1/2 act, kact and Vrev values were (in mV): WT (open circles, n = 27) 3.8 ± 0.6, 3.5 ± 0.15 and 62.4 ± 1.4; ΔF1502 (filled circles, n = 19) -17.1 ± 0.9, 4.4 ± 0.19 and 51.6 ± 2.2, respectively. Average activation (D) and deactivation (E) kinetics of WT (open circles) and ΔF1502 CaV2.1 Ca2+ currents (filled circles) at the indicated voltages.
Fig 5. ΔF1502 affects CaV2.1 channel inactivation properties.(A) Representative current traces illustrating the slower inactivation kinetics for ΔF1502 CaV2.1 channels (red trace) when compared to WT channels (blue trace), in response to a 3 s depolarizing pulse to +20 mV. (B) Average τinactivation values of Ca2+ currents through WT (open bar, n = 10) and ΔF1502 (filled bar, n = 8) CaV2.1 channels, elicited as indicated in panel (A). (C) Similar time course of Ca2+ current recovery from inactivation for WT and ΔF1502 CaV2.1 channels. Average τ of current recovery from inactivation obtained after fitting the data to a single exponential (solid color lines), were (in s): WT (open circles, n = 7) 15.5 ± 1.1; ΔF1502 (filled circles, n = 5) 16.9 ± 2.1 (P = 0.5, Student’s t test). (D, E) Steady-state inactivation of WT and ΔF1502 CaV2.1 channels. Amplitudes of currents elicited by test pulses to +20 mV (for WT channels) or -5 mV (for ΔF1502 channels) were normalized to the current obtained after a 30 s prepulse to -80 mV and fitted by a single Boltzmann function (solid color traces) (see Materials and Methods, Eq 2). Average V1/2 inact and kinact values were (in mV): WT (open circles, n = 19) -32.2 ± 2.1 and -5.3 ± 0.3; ΔF1502 (filled circles, n = 12) -60.7 ± 1 and -5.2 ± 0.8, respectively. No significant difference was found for kinact values (P = 0.89, Mann-Whitney test).
Fig 6. ΔF1502 effects on Ca2+ influx evoked by single action potential-like waveforms (APWs).(A) Average Ca2+ current traces evoked by APWs of different durations (fast (left panels), medium (central panels) and slow (right panels) (see Materials and Methods for details) obtained from tsA-201 HEK cells expressing WT (blue traces) or ΔF1502 (red traces) CaV2.1 channels. Dotted lines stand for the zero current level. (B) Average data for peak Ca2+ (ICa2+) current density (top panel), normalized Ca2+ influx (QCa2+) (second panel), time to peak (third panel), and time for Ca2+ entry (bottom panel) in response to APWs of different durations obtained from cells expressing WT (blue bars, n = 12–14) or ΔF1502 (red bars, n = 8) CaV2.1 channels (*P < 0.05, **P < 0.001 and ***P < 0.0001 when compared to WT).
Fig 7. ΔF1502 effects on Ca2+ influx evoked by a 50 Hz train of 1 ms action potential-like waveforms (APWs).(A) Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 9) and ΔF1502 (filled circles, n = 7) CaV2.1 channels expressed in tsA-201 HEK cells, before stimulation with a 50 Hz train of 1 ms APWs. In this series of experiments, maximal Ca2+ current density through CaV2.1 channels is still significantly reduced by ΔF1502 (left panel: from -100.92 ± 12.5 pA/pF (for WT, n = 9) to -47.18 ± 6.9 pA/pF (for ΔF1502, n = 7), P < 0.01, Student’s t test) and the significant left-shift induced by ΔF1502 on the CaV2.1 voltage-dependent activation is also present (right panel: WT V1/2 act = 2.27 ± 1.3 mV (n = 9) versus ΔF1502 V1/2 act = -17.73 ± 0.4 mV (n = 7), P < 0.0001, Student’s t test). (B) Representative Ca2+ current traces evoked by every 200th pulse of a 50 Hz train of fast (1 ms) APWs (see Materials and Methods for details) obtained from two tsA-201 HEK cells expressing either WT (left) or ΔF1502 (right) CaV2.1 channels. Dotted lines stand for the zero current level. The corresponding current density-voltage relationships (left) and normalized I-V curves (right), obtained from these two cells before stimulation with a 50 Hz train of fast APWs, are shown at the bottom (maximal Ca2+ current density through WT and ΔF1502 CaV2.1 channels are -91.7 pA/pF and -56.7 pA/pF, respectively; V1/2 act values for WT and ΔF1502 CaV2.1 channels are -0.5 mV and -18.97 mV, respectively). (C) Average data for Ca2+ influx normalized by cell size (QCa2+) in response to every 5th pulse of a 50 Hz train of fast (1 ms) APWs, obtained from cells expressing WT (blue symbols, n = 9) or ΔF1502 (red symbols, n = 7) CaV2.1 channels.
Fig 8. ΔF1502 effects on Ca2+ influx evoked by a 42 Hz train of 2 ms action potential-like waveforms (APWs).(A) Average current density-voltage relationships (left) and normalized I-V curves (right) for WT (open circles, n = 10) and ΔF1502 (filled circles, n = 11) CaV2.1 channels expressed in tsA-201 HEK cells, before stimulation with a 42 Hz train of 2 ms APWs. In this series of experiments, maximal Ca2+ current density through CaV2.1 channels is still significantly reduced by ΔF1502 (left panel: from -94.26 ± 18.9 pA/pF (for WT, n = 10) to -47.76 ± 5.7 pA/pF (for ΔF1502, n = 11), P < 0.05, Student’s t test) and the significant left-shift induced by ΔF1502 on the CaV2.1 voltage-dependent activation is also noticed (right panel: WT V1/2 act = 2.32 ± 1.18 mV (n = 10) versus ΔF1502 V1/2 act = -17.74 ± 0.35 mV (n = 11), P < 0.0001, Student’s t test). (B) Representative Ca2+ current traces evoked by every 200th pulse of a 42 Hz train of medium (2 ms) APWs (see Materials and Methods for details) obtained from two tsA-201 HEK cells expressing either WT (left) or ΔF1502 (right) CaV2.1 channels. Dotted lines stand for the zero current level. The corresponding current density-voltage relationships (left) and normalized I-V curves (right), obtained from these two cells before stimulation with a 42 Hz train of 2 ms APWs, are shown at the bottom (maximal Ca2+ current density through WT and ΔF1502 CaV2.1 channels are -115.28 pA/pF and -52.27 pA/pF, respectively; V1/2 act values for WT and ΔF1502 CaV2.1 channels are 2.52 mV and -17.23 mV, respectively). (C) Average data for Ca2+ influx normalized by cell size (QCa2+) in response to every 5th pulse of a 42 Hz train of medium (2 ms) APWs, obtained from cells expressing WT (blue symbols, n = 10) or ΔF1502 (red symbols, n = 11) CaV2.1 channels.
Adzhubei,
A method and server for predicting damaging missense mutations.
2010, Pubmed
Adzhubei,
A method and server for predicting damaging missense mutations.
2010,
Pubmed
Aspatwar,
Abnormal cerebellar development and ataxia in CARP VIII morphant zebrafish.
2013,
Pubmed
Blumkin,
Congenital ataxia, mental retardation, and dyskinesia associated with a novel CACNA1A mutation.
2010,
Pubmed
Bolay,
Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model.
2002,
Pubmed
Bravin,
Control of spine formation by electrical activity in the adult rat cerebellum.
1999,
Pubmed
Carreño,
Screening of CACNA1A and ATP1A2 genes in hemiplegic migraine: clinical, genetic, and functional studies.
2013,
Pubmed
Catterall,
Voltage-gated calcium channels.
2011,
Pubmed
Cricchi,
Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop.
2007,
Pubmed
Cuenca-León,
Late-onset episodic ataxia type 2 associated with a novel loss-of-function mutation in the CACNA1A gene.
2009,
Pubmed
DePristo,
A framework for variation discovery and genotyping using next-generation DNA sequencing data.
2011,
Pubmed
Di Guilmi,
Synaptic gain-of-function effects of mutant Cav2.1 channels in a mouse model of familial hemiplegic migraine are due to increased basal [Ca2+]i.
2014,
Pubmed
Ducros,
Recurrence of the T666M calcium channel CACNA1A gene mutation in familial hemiplegic migraine with progressive cerebellar ataxia.
1999,
Pubmed
Eilers,
Localized calcium signalling and neuronal integration in cerebellar Purkinje neurones.
1996,
Pubmed
Fioretti,
Trigeminal ganglion neuron subtype-specific alterations of Ca(V)2.1 calcium current and excitability in a Cacna1a mouse model of migraine.
2011,
Pubmed
Fitzsimons,
Migraine coma. Meningitic migraine with cerebral oedema associated with a new form of autosomal dominant cerebellar ataxia.
1985,
Pubmed
Fletcher,
Dystonia and cerebellar atrophy in Cacna1a null mice lacking P/Q calcium channel activity.
2001,
Pubmed
Gao,
Cerebellar ataxia by enhanced Ca(V)2.1 currents is alleviated by Ca2+-dependent K+-channel activators in Cacna1a(S218L) mutant mice.
2012,
Pubmed
García Segarra,
Congenital ataxia and hemiplegic migraine with cerebral edema associated with a novel gain of function mutation in the calcium channel CACNA1A.
2014,
Pubmed
,
Xenbase
González-Pérez,
Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.
2011,
Pubmed
Hamosh,
Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders.
2005,
Pubmed
Hirasawa,
Carbonic anhydrase related protein 8 mutation results in aberrant synaptic morphology and excitatory synaptic function in the cerebellum.
2007,
Pubmed
Hirota,
Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1.
2003,
Pubmed
Imbrici,
Late-onset episodic ataxia type 2 due to an in-frame insertion in CACNA1A.
2005,
Pubmed
,
Xenbase
Imbrici,
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia.
2004,
Pubmed
,
Xenbase
Inagaki,
Pharmacological correction of gating defects in the voltage-gated Ca(v)2.1 Ca²⁺ channel due to a familial hemiplegic migraine mutation.
2014,
Pubmed
Jiao,
Carbonic anhydrase-related protein VIII deficiency is associated with a distinctive lifelong gait disorder in waddles mice.
2005,
Pubmed
Kaplan,
The 2014 version of the gene table of monogenic neuromuscular disorders (nuclear genome).
2013,
Pubmed
Kasumu,
Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.
2012,
Pubmed
Kaya,
Phenotypical spectrum of cerebellar ataxia associated with a novel mutation in the CA8 gene, encoding carbonic anhydrase (CA) VIII.
2011,
Pubmed
Kircher,
A general framework for estimating the relative pathogenicity of human genetic variants.
2014,
Pubmed
Knierim,
Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil.
2011,
Pubmed
Kors,
Delayed cerebral edema and fatal coma after minor head trauma: role of the CACNA1A calcium channel subunit gene and relationship with familial hemiplegic migraine.
2001,
Pubmed
Kraus,
Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics.
1998,
Pubmed
,
Xenbase
Kraus,
Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics.
2000,
Pubmed
,
Xenbase
Margulies,
Identification and characterization of multi-species conserved sequences.
2003,
Pubmed
Miki,
Two novel alleles of tottering with distinct Ca(v)2.1 calcium channel neuropathologies.
2008,
Pubmed
Mikoshiba,
IP3 receptor/Ca2+ channel: from discovery to new signaling concepts.
2007,
Pubmed
Mori,
Reduced voltage sensitivity of activation of P/Q-type Ca2+ channels is associated with the ataxic mouse mutation rolling Nagoya (tg(rol)).
2000,
Pubmed
Naik,
Early-onset cerebellar atrophy associated with mutation in the CACNA1A gene.
2011,
Pubmed
Ng,
SIFT: Predicting amino acid changes that affect protein function.
2003,
Pubmed
Oelstrom,
Evolutionarily conserved intracellular gate of voltage-dependent sodium channels.
2014,
Pubmed
Ossowski,
Sequencing of natural strains of Arabidopsis thaliana with short reads.
2008,
Pubmed
Pattillo,
Variations in onset of action potential broadening: effects on calcium current studied in chick ciliary ganglion neurones.
1999,
Pubmed
,
Xenbase
Pelzer,
Familial and sporadic hemiplegic migraine: diagnosis and treatment.
2013,
Pubmed
Pettersen,
UCSF Chimera--a visualization system for exploratory research and analysis.
2004,
Pubmed
Pietrobon,
Neurobiology of migraine.
2003,
Pubmed
Pietrobon,
CaV2.1 channelopathies.
2010,
Pubmed
Pietrobon,
Familial hemiplegic migraine.
2007,
Pubmed
Pietrobon,
Pathophysiology of migraine.
2013,
Pubmed
Pineda,
Specificity in the interaction of HVA Ca2+ channel types with Ca2+-dependent AHPs and firing behavior in neocortical pyramidal neurons.
1998,
Pubmed
Rajakulendran,
Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy.
2010,
Pubmed
Rose,
The first knockin mouse model of episodic ataxia type 2.
2014,
Pubmed
Scoggan,
CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid.
2006,
Pubmed
Serra,
The hemiplegic migraine-associated Y1245C mutation in CACNA1A results in a gain of channel function due to its effect on the voltage sensor and G-protein-mediated inhibition.
2009,
Pubmed
Serra,
A mutation in the first intracellular loop of CACNA1A prevents P/Q channel modulation by SNARE proteins and lowers exocytosis.
2010,
Pubmed
Sotelo,
Climbing fiber deafferentation: its action on Purkinje cell dendritic spines.
1975,
Pubmed
Spacey,
Functional implications of a novel EA2 mutation in the P/Q-type calcium channel.
2004,
Pubmed
Strupp,
Episodic ataxia type 2.
2007,
Pubmed
Sutton,
P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A.
1999,
Pubmed
Terwindt,
Variable clinical expression of mutations in the P/Q-type calcium channel gene in familial hemiplegic migraine. Dutch Migraine Genetics Research Group.
1998,
Pubmed
Tottene,
Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Ca(v)2.1 knockin migraine mice.
2009,
Pubmed
Tottene,
Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma.
2005,
Pubmed
Tranchevent,
ENDEAVOUR update: a web resource for gene prioritization in multiple species.
2008,
Pubmed
Türkmen,
CA8 mutations cause a novel syndrome characterized by ataxia and mild mental retardation with predisposition to quadrupedal gait.
2009,
Pubmed
Vecchia,
Mechanism underlying unaltered cortical inhibitory synaptic transmission in contrast with enhanced excitatory transmission in CaV2.1 knockin migraine mice.
2014,
Pubmed
Vila-Pueyo,
A loss-of-function CACNA1A mutation causing benign paroxysmal torticollis of infancy.
2014,
Pubmed
Wada,
Wide clinical variability in a family with a CACNA1A T666m mutation: hemiplegic migraine, coma, and progressive ataxia.
2002,
Pubmed
Wan,
CACNA1A mutations causing episodic and progressive ataxia alter channel trafficking and kinetics.
2005,
Pubmed
Wang,
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.
2010,
Pubmed
Wappl,
Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia.
2002,
Pubmed
,
Xenbase
Watase,
Spinocerebellar ataxia type 6 knockin mice develop a progressive neuronal dysfunction with age-dependent accumulation of mutant CaV2.1 channels.
2008,
Pubmed
Westenbroek,
Immunochemical identification and subcellular distribution of the alpha 1A subunits of brain calcium channels.
1995,
Pubmed
Womack,
Calcium-activated potassium channels are selectively coupled to P/Q-type calcium channels in cerebellar Purkinje neurons.
2004,
Pubmed
Zanni,
Mutation of plasma membrane Ca2+ ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+ homeostasis.
2012,
Pubmed
Zhong,
Reciprocal regulation of P/Q-type Ca2+ channels by SNAP-25, syntaxin and synaptotagmin.
1999,
Pubmed
Zhuchenko,
Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.
1997,
Pubmed
van den Maagdenberg,
A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression.
2004,
Pubmed
van den Maagdenberg,
High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice.
2010,
Pubmed